Extrahepatic biliary obstruction after percutaneous tumour ablation for hepatocellular carcinoma: Aetiology and successful treatment with endoscopic papillary balloon dilatation

Gut

Volumn 54, Issue 5, 2005, Pages 698-702

  Sasahira, N ^b   Tada, M ^a,b   Yoshida, H ^b   Tateishi, R ^b   Shiina, S ^b   Hirano, K ^b   Isayama, H ^b   Toda, N ^b   Komatsu, Y ^b   Kawabe, T ^b   Omata, M ^b  

^a University of Tokyo ^*  (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BALLOON DILATATION; BILE DUCT OBSTRUCTION; BILIARY CAST; BILIARY TRACT DRAINAGE; CANCER GROWTH; CAUSE OF DEATH; ENDOSCOPIC PAPILLARY BALLOON DILATATION; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; FOLLOW UP; GALLSTONE; HEMOBILIA; HUMAN; INCIDENCE; INJECTION; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERCUTANEOUS TUMOR ABLATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BALLOON DILATATION; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLESTASIS, EXTRAHEPATIC; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 20244375385     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.038331     Document Type: Article

References (39)

1. Shiratori Y, Shiina S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995;22:1027-33.
2. Taylor-Robinson SD, Foster GR, Arora S, et al. Increase in primary liver cancer in the UK, 1979-1994. Lancet 1997;350:1142-3.
3. Hashem BE, Andrew CM. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
4. Poon RT, Fan ST, Tsang FH, et al. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002;235:466-8.
5. Shiina S, Teratani T, Obi S, et al. Percutaneous ethanol injection therapy for liver tumors. European J Ultrasound 2001;13:95-106.
6. Teratoni T, Ishikawa T, Shiratori Y, et al. Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy. Cancer 2002;95:816-23.
7. Shiina S, Teratani T, Obi S, et al. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002;62:64-8.
8. Di Stasi M, Buscarini L, Livraghi T, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 1997;32:1168-73.
9. Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumors. Br J Surg 2002;89:1206-22.
10. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complication encountered in a multicenter study. Radiology 2003;226:441-51.
11. Kajiro M, Kawabata K, Kawano W, et al. Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases. Cancer 1982;49:2144-7.
12. Lau WY, Leung JW, Li AK. Management of hepatocellular carcinoma presenting as obstructive jaundice. Am J Surg 1990;160:280-2.
13. Chen MF, Jan YY, Jeng LB, et al. Obstructive jaundice secondary to ruptured hepatocellular carcinoma into the common bile duct. Surgical experiences of 20 cases. Cancer 1994;73:1335-40.
14. Bouchier IA. Postmortem study of the frequency of gallstones in patients with cirrhosis of the liver. Gut 1969;10:705-10.
15. Dario C, Mirella F, Fabio F, et al. Close relation between cirrhosis and gallstones: Cross-sectional and longitudinal survey. Arch Intern Med 1999;159:49-52.
16. Koda M, Murawaki Y, Idobe Y, et al. Is choledocholithiasis a late complication of nonresectional therapies for hepatocellular carcinoma? Hepatogastroenterology 1999;46:3091-4.
17. Gigot JF, Lesse T, Dereme T, et al. Acute cholangitis. Multivariate analysis of risk factors. Ann Surg 1989;209:435-8.
18. Lai EC, Mok FP, Tan ES, et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med 1992;326:1582-6.
19. Chijiiwa K, Kozaki N, Naito T, et al. Treatment of choice for choledocholithiasis in patients with acute obstructive suppurative cholangitis and liver cirrhosis. Am J Surg 1995;170:356-60.
20. Sirinek KR, Burk RR, Brown M, et al. Improving survival in patients with cirrhosis undergoing major abdominal operations. Arch Surg 1987;122:271-3.
21. Sugiyama M, Atomi Y, Kuroda A, et al. Treatment of choledocholithiasis in patients with liver cirrhosis. Surgical treatment or endoscopic sphincterotomy? Ann Surg 1993;218:68-73.
22. Freeman ML, Nelson DB, Sherman S, et al. Complication of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-18.
23. Van Os EC, Kamath PS, Gostout O, et al. Gastroenterological procedures among patients with disorders of hemostasis: evaluation and management recommendations. Gastrointest Endosc 1999;50:536-43.
24. Kawabe T, Komatsu Y, Tada M, et al. Endoscopic papillary balloon dilatation in cirrhotic patients: Removal of common bile duct stones without sphincterotomy. Endoscopy 1996;28:694-8.
25. Komatsu Y, Kawabe T, Toda N, et al. Endoscopic papillary balloon dilatation for the management of bile duct stones; Experience of 226 cases. Endoscopy 1998;30:12-17.
26. Bergman JJGHM, Rauws EAJ, Fockens P, et al. Randomized trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bile duct stones. Lancet 1997;349:1124-9.
27. Fujita N, Maguchi H, Komatsu Y, for the JESED study group, et al. Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial. Gastrointest Endosc 2003;57:151-5.
28. Waldram R, Williams R, Calne Y. Bile composition and bile cast formation after transplantation of the liver in man. Transplantation 1975;19:382-7.
29. Chen CHL, Wang KL, Chuang JH, et al. Biliary sludge-cast formation following liver transplantation. Hepatogastroenterology 1988;35:22-4.
30. Ward EM, Kiely MJ, Maus TP, et al. Hilar biliary strictures after liver transplantation: Cholangiography and percutaneous treatment. Radiology 1990;177:259-63.
31. Sheng R, Ramirez CB, Zajko AB, et al. Biliary stones and sludge in liver transplant patients: A 13-year experience. Radiology 1996;198:243-7.
32. Shah JN, Haigh WG, Lee SP, et al. Biliary casts after orthotopic liver transplantation: clinical factors, treatment, biochemical analysis. Am J Gastroenterol 2003;98:1861-7.
33. Baron TH, Yates RM iii, Morgan DE, et al. Biliary cast syndrome: Successful endoscopic treatment. Gastrointest Endosc 2000;52:78-9.
34. Obi S, Shiratori Y, Shiina S, et al. Early detection of haemobilia associated with percutaneous ethanol injection for hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2000;12:285-90.
35. Joo YE, Kim HS, Choi SK, et al. Haemobilia caused by liver abscess due to intrahepatic duct stones. J Gastroenterol 2003;38:507-11.
36. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-93.
37. Lau WY, Leung KL, Leung TW, et al. A logical approach to hepatocellular carcinoma presenting with jaundice. Ann Surgery 1997;225:281-5.
38. Tarazov PG, Porysalv VN. Prozorovsky KV, et al. Ischemic complications of transcatheter arterial chemoembolization in liver malignancies. Acta Radiol 2000;41:156-60.
39. Yu JS, Kim KW, Park MS, et al. Bile duct injuries leading to portal vein obliteration after transcatheter arterial chemoembolization in the liver. CT findings and initial observations. Radiology 2001;221:429-36.